← Back to Search

Behavioral Intervention

Tai Chi for Osteoarthritis Pain Management

N/A
Waitlist Available
Led By Chwan-Li Shen
Research Sponsored by Texas Tech University Health Sciences Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
WOMAC pain score ≥ 50 on at least 1 of the 5 questions in pain subscale (range of 0 to 100, with higher scores indicating greater pain)
Diagnosed with the following symptoms associated with knee OA based on American College of Rheumatology clinical classification criteria for osteoarthritis (Peat 2006): Pain in the knee and at least 3 of the following: over 50 years of age, less than 30 minutes of morning stiffness, crepitus on active motion, bony tenderness, bony enlargement, or no palpable warmth of synovium.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up changes from baseline sf-36 results at 8 weeks
Awards & highlights

Study Summary

This trial is to see if Tai Chi has an effect on plasma endocannabinoid levels and other things in women with knee OA.

Who is the study for?
This trial is for postmenopausal women with knee osteoarthritis pain who can read English and have an MRI scan. They must have knee pain with specific symptoms like morning stiffness or bony tenderness, and a certain level of pain on the WOMAC scale. Women who've recently done mind-body practices or had certain treatments for knee OA cannot join.Check my eligibility
What is being tested?
The study tests how Tai Chi exercise over 8 weeks affects substances in the blood related to inflammation and brain factors, as well as changes in brain connectivity and improvements in function and clinical outcomes for women suffering from knee osteoarthritis.See study design
What are the potential side effects?
Tai Chi is generally considered safe but may include muscle soreness, joint strain, or falls if not performed correctly. Since it's a low-impact exercise, serious side effects are rare.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have a pain score of 50 or more on the WOMAC scale.
Select...
I am over 50, have knee pain, stiffness under 30 mins, knee sounds, tenderness, or swelling but no warmth.
Select...
I am a woman who has gone through menopause.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~changes from bseline endocannabinoid levels at 8 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and changes from bseline endocannabinoid levels at 8 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
endocannabinoid
oxylipins
Secondary outcome measures
BDNF
Pain assessment
Quality of life assessment
+4 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Tai Chi interventionExperimental Treatment1 Intervention
24-form Yang style Tai Chi
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Tai chi exercise
Completed Phase 1
Unknown

Find a Location

Who is running the clinical trial?

Texas Tech University Health Sciences CenterLead Sponsor
104 Previous Clinical Trials
10,741 Total Patients Enrolled
2 Trials studying Osteoarthritis
10 Patients Enrolled for Osteoarthritis
Chwan-Li ShenPrincipal InvestigatorTexas Tech University Health Sciences Center

Media Library

Tai chi exercise (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04046003 — N/A
Osteoarthritis Research Study Groups: Tai Chi intervention
Osteoarthritis Clinical Trial 2023: Tai chi exercise Highlights & Side Effects. Trial Name: NCT04046003 — N/A
Tai chi exercise (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04046003 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the desired outcome of this medical research endeavor?

"The objective of this trial is to assess changes from baseline endocannabinoid and oxylipin levels after 8 weeks. Secondary outcomes include measuring plasma brain-derived neurotrophic factor, analyzing expression of endocannabioid receptors on peripheral blood mononuclear cells, and examining white matter connectivity/efficiency in the brain via diffusion tensor imaging. Blood collection will involve a Leucosep tube with Ficoll-Paque while DTI images are obtained using echo planar imaging at 60 directions with b-value 1000s/mm2."

Answered by AI

Is this research endeavor open to recruitment at present?

"As per information on clinicaltrials.gov, recruitment for this trial has been suspended. Initially posted in September 2019 and last updated in late 2022, it is not at present soliciting patients; however, there are 694 other trials actively recruiting right now."

Answered by AI
~1 spots leftby Jun 2024